FDA Letter APOTEX ANDA 206066

Letter

ANDA 206066

APOTEX

Application #206066

Documents

Letter2019-04-24

Application Sponsors

ANDA 206066APOTEX
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.